Training Program in Personalized Cardiovascular Medicine (TPIPCVM)

个性化心血管医学培训计划 (TPIPCVM)

基本信息

  • 批准号:
    10204788
  • 负责人:
  • 金额:
    $ 49.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

TRAINING IN PERSONALIZED CARDIOVASCULAR MEDICINE (TPIPCVM) Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
个性化心血管医学培训(TPIPCVM) 项目摘要 心血管疾病(CVD)仍然是老年人中显著发病率和死亡率的主要原因。 美国特别是在风险因素负担很高的少数民族中。个性化医疗是一种 快速发展的医疗保健领域,个人独特的基因组、环境和临床 分析背景以确定对疾病的易感性,预测其临床过程, 具体治疗。尽管最近在CV基因组学方面取得了进展,但我们无法将治疗靶向 个体患者的潜在机制,未能将这些科学发现转化为 患者的床边护理和少数民族纳入翻译简历的障碍 研究限制了我们实现个性化医疗承诺的能力。此外,委员会认为, 传统的培训计划不再能够为学员提供必要的技能, 实施正在进行的个性化医疗革命。因此,培训的主要目标 个性化心血管医学计划(TPIPCVM)旨在使学员成为 CV基因组学的领导者,并接受分子,细胞,疾病和整体动物建模方面的培训 以及CVD的临床和转化方法,以便将这些新知识转化为 最佳循证个性化CV护理。我们将招募高素质和积极性的前, 博士后培训生,并为他们提供CV基因组学方面的最高水平培训 从我们的教师在心脏病学部门和我们的合作伙伴在UIC现有的优势。的3 研究重点:1)心律失常; 2)缺血性和非缺血性心肌病;和 心血管病相关代谢综合征相互之间高度相关,与心血管疾病的发生、发展直接相关。 个性化CV基因组学的中心主题。TPIPCVM的首要目标是培训 下一代CV研究者创造新知识并实施最佳循证医学 个性化医疗TPIPCVM导师是非常成功的医生科学家/科学家 与研究,指导和合作谁提供一流的内部和多方面的证明记录, 纪律培训机会。该培训计划的主要优势包括: 学员的综合基础科学分子,细胞和整个病人的方法,以确定 CVD的基本机制;教师的跟踪记录和他们的共同研究兴趣, 个性化CV基因组学;个性化CV医学的专门培训;以及 将科学发现应用于在医院接受治疗的多样化和代表性不足的患者群体, UIC医疗中心TPIPCVM着手培养2名博士前和2名博士后学生 每年。总的来说,这个培训计划提供了一个独特的培训经验,并满足了迫切的需求。 需要个性化CV医学培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dawood Darbar其他文献

Dawood Darbar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dawood Darbar', 18)}}的其他基金

Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10671651
  • 财政年份:
    2020
  • 资助金额:
    $ 49.28万
  • 项目类别:
Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10453452
  • 财政年份:
    2020
  • 资助金额:
    $ 49.28万
  • 项目类别:
Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
人 iPSC 衍生的心房心肌细胞在培养皿中模拟心房颤动
  • 批准号:
    10549330
  • 财政年份:
    2020
  • 资助金额:
    $ 49.28万
  • 项目类别:
Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish
人 iPSC 衍生的心房心肌细胞在培养皿中模拟心房颤动
  • 批准号:
    10548469
  • 财政年份:
    2020
  • 资助金额:
    $ 49.28万
  • 项目类别:
Genotype-guided therapy for atrial fibrillation
心房颤动的基因型引导治疗
  • 批准号:
    10215617
  • 财政年份:
    2020
  • 资助金额:
    $ 49.28万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10477286
  • 财政年份:
    2019
  • 资助金额:
    $ 49.28万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10266061
  • 财政年份:
    2019
  • 资助金额:
    $ 49.28万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    9974275
  • 财政年份:
    2019
  • 资助金额:
    $ 49.28万
  • 项目类别:
Obesity-Mediated Atrial Fibrillation: Underlying Mechanisms and Responsiveness to Antiarrhythmic Therapy
肥胖介导的心房颤动:潜在机制和抗心律失常治疗的反应
  • 批准号:
    10905978
  • 财政年份:
    2019
  • 资助金额:
    $ 49.28万
  • 项目类别:
Training Program in Personalized Cardiovascular Medicine (TPIPCVM)
个性化心血管医学培训计划 (TPIPCVM)
  • 批准号:
    10454147
  • 财政年份:
    2018
  • 资助金额:
    $ 49.28万
  • 项目类别:

相似国自然基金

Chinese Journal of Integrative Medicine
  • 批准号:
    81224004
  • 批准年份:
    2012
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Planning: FIRE-PLAN: Exploring fire as medicine to revitalize cultural burning in the Upper Midwest
规划:FIRE-PLAN:探索火作为药物,以振兴中西部北部的文化燃烧
  • 批准号:
    2349282
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Standard Grant
Amalgamating Evidence About Causes: Medicine, the Medical Sciences, and Beyond
合并有关原因的证据:医学、医学科学及其他领域
  • 批准号:
    AH/Y007654/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Research Grant
CageTag: Caged Theranostics as a Universal Platform for Nuclear Medicine
CageTag:笼式治疗诊断学作为核医学的通用平台
  • 批准号:
    EP/V055836/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London Sch of Hygiene & Tropic. Medicine
2024 年开放访问区块奖 - 伦敦卫生学院
  • 批准号:
    EP/Z532368/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Research Grant
Personalised Adaptive Medicine
个性化适应性医学
  • 批准号:
    10100435
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    EU-Funded
関節リウマチにおけるPrecision medicine達成のための科学的根拠の確立
为实现类风湿关节炎精准医疗奠定科学基础
  • 批准号:
    24K11609
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
胆道癌における相同組換え修復欠損に基づいたprecision medicineの構築
基于胆道癌同源重组修复缺陷的精准医疗构建
  • 批准号:
    24K11926
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
  • 批准号:
    2226026
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Cooperative Agreement
REU site: Research at the interface between engineering and medicine (ENGMED)
REU 网站:工程与医学之间的交叉研究 (ENGMED)
  • 批准号:
    2349731
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Standard Grant
NSF Engines: Piedmont Triad Regenerative Medicine Engine
NSF 引擎:Piedmont Triad 再生医学引擎
  • 批准号:
    2315654
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了